Publication | Closed Access
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase
16
Citations
74
References
2018
Year
Inhibitory ActivityAntiparasitic AgentMedicineDrug DiscoveryRna PolymerasePharmacotherapyAntimicrobial ChemotherapyDrug DevelopmentPharmacologyAntimicrobial ResistanceBiomolecular EngineeringDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1